Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica - United States
doi 10.1111/aos.13540
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Macular Atrophy in Neovascular Age Related Macular Degeneration

Journal of Clinical Review & Case Reports
2019English

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016English

Pss62 - Treatment Preference Drivers of Patients With Neovascular Age-Related Macular Degeneration

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Baseline Predictors for One-Year Visual Outcomes With Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2013English

Macular Functional Changes in Patients With Neovascular Age-Related Macular Degeneration Receiving Ranibizumab Therapy (Lucentis)

BMC Geriatrics
GerontologyGeriatrics
2010English

Relationship Between Foveal Birefringence and Visual Acuity in Neovascular Age-Related Macular Degeneration

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2006English

Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration in Patients Aged 90 Years or Older: 2-Year Visual Acuity Outcomes

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2018English

Neovascular Age-Related Macular Degeneration Is Associated With Cataract Surgery

Acta Ophthalmologica
MedicineOphthalmology
2017English

The Carnitine Shuttle Pathway Is Altered in Patients With Neovascular Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy